Skip to main content
. 2021 Jul 1;2:668781. doi: 10.3389/falgy.2021.668781

Table 2.

Passive immunization with or topical application of monoclonal allergen-specific IgG antibody for treatment of IgE-mediated allergy.

Passive immunization Topical application
Requires IgE blocking antibodies May be performed with single non-IgE blocking antibodies
Requires full antibodies with long serum half-life Can be done with antibody fragments or small scaffolds
Works only for certain less complex allergens and allergen sources Can be used for complex allergens and allergen sources
One systemic administration sufficient for up to 3 months Daily topical administration
Only for allergy treatment Suitable also for treatment of RV infections with a blocking ICAM-1 antibody